PUMA BIOTECHNOLOGY, INC. - COM (PBYI)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
31M
Holdings value Q2 2024
$101M
Value change Q2 2024
-$1.24M
Grand Portfolio weight change Q2 2024
0%
Number of holders
98
Number of buys Q2 2024
8
Number of sells Q2 2024
-7
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 521K $1.33M -$238K $2.55 18
2024 Q2 31M $101M -$1.24M $3.26 98
2024 Q1 29.7M $158M +$17.1M $5.30 96
2023 Q4 26.6M $115M +$4.77M $4.33 82
2023 Q3 25.7M $67.6M -$2.43M $2.63 68
2023 Q2 26.6M $93.8M -$4.38M $3.53 68
2023 Q1 27.9M $86.1M -$528K $3.09 77
2022 Q4 27.5M $116M -$139K $4.23 86
2022 Q3 27.6M $65.5M -$1.73M $2.37 71
2022 Q2 27.9M $79.5M -$4.14M $2.85 77
2022 Q1 29.9M $86.1M -$477K $2.88 96
2021 Q4 30.3M $92.2M -$39.5M $3.04 96
2021 Q3 32.2M $225M -$28.7M $7.01 113
2021 Q2 34.8M $319M -$17.3M $9.18 119
2021 Q1 36.6M $356M +$13.7M $9.72 117
2020 Q4 35.3M $362M -$9.27M $10.26 120
2020 Q3 38.7M $390M +$12.9M $10.09 128
2020 Q2 35.1M $366M -$6.25M $10.43 124
2020 Q1 36.6M $309M +$43.2M $8.44 120
2019 Q4 31.3M $274M -$64.6M $8.75 130
2019 Q3 36.6M $394M +$16.1M $10.77 138
2019 Q2 34.8M $442M -$104M $12.71 133
2019 Q1 34.2M $1.32B +$17.9M $38.79 159
2018 Q4 35.2M $716M -$228M $20.35 136
2018 Q3 35.6M $1.63B -$26.4M $45.85 154
2018 Q2 35.9M $2.13B -$1.06M $59.15 169
2018 Q1 35.6M $2.42B -$81.3M $68.05 167
2017 Q4 36.2M $3.57B -$112M $98.85 195
2017 Q3 36.7M $4.39B +$170M $119.75 170
2017 Q2 35.5M $3.1B +$61.7M $87.40 152
2017 Q1 37.9M $1.41B +$190M $37.20 135
2016 Q4 34.9M $1.07B +$72.9M $30.70 127
2016 Q3 30M $2.01B +$2.04M $67.05 145
2016 Q2 31.6M $943M +$45M $29.79 105
2016 Q1 30.3M $890M -$135M $29.37 112
2015 Q4 32.2M $2.52B +$179M $78.40 130
2015 Q3 30.1M $2.27B -$40.6M $75.36 158
2015 Q2 30.5M $3.55B -$39.1M $116.75 197
2015 Q1 29.1M $6.87B +$478M $236.11 199
2014 Q4 27.1M $5.14B +$68.5M $189.27 184
2014 Q3 26.7M $6.37B +$472M $238.57 185
2014 Q2 25.4M $1.67B -$41.8M $66.00 133
2014 Q1 25.1M $2.61B +$110M $104.14 133